Looks really good although some question to be raised taking a pessimistic view, all may be very explainable though:
1. Another 4-6 months of trialing are needed to run 'Phase 2' - considering you have TGA approval not sure how long this thing needs to be trialed.
2. What is phase 2 as sounds like just more of phase 1 in a different location?
3. Why are we moving to another state when if this was so great the existing state would want to keep utilising it and push to commercialisation sooner? Do they want to see another state independently verify results?
4. Possibly Covid related to a safer environment though by switching states? But no mention of this.
5. Could there be some reluctance of I'Med and others to want to now pay a 3rd party company a fee for what they would normally otherwise obtain a similar result with another imaging technology?
6. Is the additional cost paid by Medicare? We have not heard much more on this.
Also like how they address the December 2020 'commercial scan' issues I had previously raised but we can now see all along they should have said first Clinical Pilot scan conducted as part of a trial to secure a commercial agreement - not first commercial scan done with rollout nation wide in the new year.
"The scan was successfully completed in Victoria and marks the first commercial use of XV LVAS as the
Company begins to roll out its infrastructure nationally. Installation of XV LVAS is anticipated in hospitals
and imaging centres in Victoria as well as other states from early 2021."
- Forums
- ASX - By Stock
- 4DX
- Ann: 4DMedical advances Australian clinical pilot with I-MED
Ann: 4DMedical advances Australian clinical pilot with I-MED, page-4
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 4DX (ASX) to my watchlist
(20min delay)
|
|||||
Last
55.5¢ |
Change
-0.015(2.63%) |
Mkt cap ! $227.8M |
Open | High | Low | Value | Volume |
58.0¢ | 58.5¢ | 55.5¢ | $240.7K | 424.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 28607 | 55.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
57.0¢ | 8902 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 28607 | 0.555 |
4 | 224181 | 0.550 |
2 | 29000 | 0.545 |
2 | 10936 | 0.535 |
5 | 60897 | 0.530 |
Price($) | Vol. | No. |
---|---|---|
0.570 | 8902 | 1 |
0.575 | 17391 | 1 |
0.580 | 25000 | 2 |
0.585 | 20123 | 2 |
0.590 | 62662 | 3 |
Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
Featured News
4DX (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, Managing Director & CEO
Charles Armstrong
Managing Director & CEO
SPONSORED BY The Market Online